English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Sh. A. Sadigova

    NEONATAL DYNAMICS OF NEURON-SPECIFIC ENOLASE IN NEWBORNS WITH POSTHYPOXIC ENCEPHALOPATHY


    About the author: Sh. A. Sadigova
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The purpose of the study was to determine the informativeness of neuron specific enolase in prediction of the course of posthypoxic encephalopathy in newborns. 68 newborns with posthypoxic encephalopathy were included in the study (main groups): group I – 41 premature children (28–36 weeks of gestation), divided into 2 subgroups: subgroup IA (n=19; 28–31 weeks of gestation), subgroup IB (n=22; 32–36 weeks of gestation); group II – 27 full-term children (37–40 weeks of gestation). The control group consisted of 29 children without perinatal asphyxia. Neurosonography and determination of neuron specific enolase in blood serum were performed in dynamics of neonatal period. According to results, compared to the control group, the concentration of neuron specific enolase was higher in children with perinatal asphyxia, the highest level was noted in group IB. The levels of neuron specific enolase in the dynamics of the early neonatal period (days 1–3; 5–7) was twice as high in newborns of subgroups with structural changes of the brain, compared to subgroup without structural changes on neurosonography. Thus, it is obvious, that neuron specific enolase can be used in practice to predict the course of posthypoxic encephalopathy.
    Tags perinatal asphyxia,newborns,neuron specific proteins,neurosonography,neonatal brain damages
    Bibliography
    • Andelius TCK, Kyng KJ, Heiring C, Henriksen TB. Asphyxia and hypoxic-ischaemic encephalopathy. Ugeskr Laeger. 2020 Mar 30;182(14A): V12190704. [in Danish]
    • Bersani I, Piersigilli F, Gazzolo D, Campi F, Savarese I, Dotta A, et al. Heart rate variability as possible marker of brain damage in neonates with hypoxic ischemic encephalopathy: a systematic review. Eur J Pediatr. 2021 May;180(5):1335–1345. doi:  10.1007/s00431-020-03882-3.
    • Boardman JP, Ireland G, Sullivan G, Pataky R, Fleiss B, Gressens P, et al. The Cerebrospinal Fluid Inflammatory Response to Preterm Birth. Front Physiol. 2018 Sep 12; 9:1299. doi: 10.3389/fphys.2018.01299.
    • Graham EM, Everett AD, Delpech JC, Northington FJ. Blood biomarkers for evaluation of perinatal encephalopathy: state of the art. Curr Opin Pediatr. 2018 Apr;30(2):199–203. doi: 10.1097/MOP.0000000000000591.
    • Gromova AM, Berezhna VA, Gromova OL, Lyakhovska TY, Ketova OM. Soluble endoglin as an early prediction marker of intrauterine growth retardation. World of Medicine and Biology. 2021; 4(78): 041–045. doi: 10.26724/2079-8334-2021-4-78-41-45
    • Isgrò MA, Bottoni P, Scatena R. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Adv Exp Med Biol. 2015; 867:125–43. doi: 10.1007/978-94-017-7215-0_9.
    • Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016 Dec 17;388(10063):3027–3035. doi: 10.1016/S0140-6736(16)31593-8.
    • Lundgren C, Brudin L, Wanby AS, Blomberg M. Ante- and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy. J Matern Fetal Neonatal Med. 2018 Jun;31(12):1595–1601. doi: 10.1080/14767058.2017.1321628. 
    • Lv H, Wang Q, Wu S, Yang L, Ren P, Yang Y, Gao J, Li L. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015 Oct 23; 450:282–97. doi: 10.1016/j.cca.2015.08.021.
    • Mrelashvili A, Russ JB, Ferriero DM, Wusthoff CJ. The Sarnat score for neonatal encephalopathy: looking back and moving forward. Pediatr Res. 2020 Dec;88(6):824–825. doi: 10.1038/s41390-020-01143-5.
    • O’Dea M, Sweetman D, Bonifacio SL, El-Dib M, Austin T, Molloy EJ. Management of Multi Organ Dysfunction in Neonatal Encephalopathy. Front Pediatr. 2020; 8:239. doi:10.3389/fped.2020.00239.
    • Pei XM, Gao R, Zhang GY, Lin L, Wan SM, Qiu SQ. [Effects of erythropoietin on serum NSE and S-100B levels in neonates with hypoxic-ischemic encephalopathy]. Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jul;16(7):705–8. PMID: 25008877. [in Chinese]
    • Peng H, Pu YH. [Dynamic changes in serum neuron-specific enolase levels in neonates]. Zhongguo Dang Dai Er Ke Za Zhi. 2014 Nov;16(11):1122–4. PMID: 25406556. [in Chinese]
    • Thornton C, Leaw B, Mallard C, Nair S, Jinnai M, Hagberg H. Cell Death in the Developing Brain after Hypoxia-Ischemia. Front Cell Neurosci. 2017 Aug 23; 11:248. doi: 10.3389/fncel.2017.00248.
    • Walas W, Wilińska M, Bekiesińska-Figatowska M, Halaba Z, Śmigiel R. Methods for assessing the severity of perinatal asphyxia and early prognostic tools in neonates with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia. Adv Clin Exp Med. 2020 Aug;29(8):1011–1016. doi: 10.17219/acem/124437. PMID: 32820870.
    Publication of the article «World of Medicine and Biology» №4(86), 2023 year, 133-137 pages, index UDK 616.831-001.8 - 053.32
    DOI 10.26724/2079-8334-2023-4-86-133-137